Pharma channel feed

#AAD25: What you need to know from Am­gen, Bris­tol My­ers, J&J and more

2 months ago
R&D

Sun Phar­ma to ac­quire Check­point Ther­a­peu­tics and its an­ti-PD-L1 an­ti­body

2 months ago
Deals

Min­eralys’ Phase 3 blood pres­sure pill da­ta sup­port po­ten­tial FDA ap­proval

2 months ago
R&D

Start of 2025 comes with gener­ic drug price de­creas­es, sev­er­al ma­jor in­creas­es, re­port finds

2 months ago

FDA ap­proves Neu­rotech cell ther­a­py to slow a rare de­gen­er­a­tive eye dis­ease 

2 months ago
FDA+

Bay­er eyes cap­i­tal raise as it grap­ples with Mon­san­to cas­es

2 months ago
Law

At $300M Kardi­gan start­up, for­mer MyoKar­dia team un­veils its first drug, and it comes from Io­n­is

2 months ago
Startups
Deals

J&J ax­es Phase 3 de­pres­sion pro­gram due to ‘in­suf­fi­cient ef­fi­ca­cy’ short­ly af­ter Neumo­ra’s study fail

2 months ago
R&D

Mod­er­na stands by its Covid vac­cine IP af­ter de­ci­sion ax­ing two patents

2 months ago
Coronavirus
Law

Mer­ck KGaA says ear­li­er moves to lo­cal­ize man­u­fac­tur­ing help ease Trump tar­iff im­pact 

2 months ago
China
Manufacturing

Live up­dates: Makary like­ly a lock for next FDA chief af­ter breezy Sen­ate hear­ing

2 months ago
People
FDA+

No news is good news? Mer­ck KGaA qui­et on po­ten­tial Spring­Works takeover

2 months ago
Deals

Judge grants new na­tion­wide block on NIH pay­ment cuts 

2 months ago
FDA+
Law

Bavar­i­an Nordic CEO says it can take years to move phar­ma man­u­fac­tur­ing to the US

2 months ago
Manufacturing

No­vo Nordisk slash­es We­govy price by near­ly two-thirds for cash-pay­ing pa­tients

2 months ago
Marketing

Live up­dates: Trump NIH pick Bhat­tacharya sails through Sen­ate hear­ing, side­step­ping con­tro­ver­sy

2 months ago
People
Law

Up­dat­ed: Jazz to buy Chimerix to get brain tu­mor drug five months ahead of PDU­FA

2 months ago
Deals

Bay­er cau­tions phar­ma sales dip this year de­spite ma­jor up­com­ing launch­es

2 months ago

In an un­usu­al move, Lil­ly seeks pitch­es from US states for slice of $27B build­out

2 months ago
Manufacturing

Bourla says Pfiz­er could trans­fer pro­duc­tion to US to side­step Trump's tar­iffs

2 months ago
Manufacturing

GSK, Am­gen and As­traZeneca tout Phase 3 da­ta in in­flam­ma­to­ry nasal con­di­tion 

2 months ago
R&D

ICER finds GSK in­halers of­fer ad­van­tages over gener­ic com­peti­tors

2 months ago

Ab­b­Vie fi­nal­ly en­ters obe­si­ty race with $350M up­front for Gubra’s amylin

2 months ago
Deals

At least eight drug­mak­ers say they will par­tic­i­pate in round two of IRA ne­go­ti­a­tions 

3 months ago
FDA+
First page Previous page 11121314151617 Next page Last page
A service from the Financial Times